MONROVIA, CA, March 19, 2009
/24-7PressRelease/ -- Due to the unmet needs of ocular disease drug therapies and the growing population of aging individuals, GTCbio is proud to announce its inaugural Ocular Diseases & Drug Discovery conference, taking place on April 20-21, 2009 in Philadelphia, PA.
In 2005, the National Eye Institute (NEI) estimated that the annual cost of vision impairment and eye disease to the United States was $68 billion. Not only are eye diseases costly to the US, they also impact the quality of life of over 34 million people, causing lost productivity, reduced independence, diminished quality of life, increased depression and accelerated mortality. By 2020, this number is expected to grow to over 50 million.
To help promote the discovery and developments of ocular disease, GTCbio is bringing together leading scientists, researchers, and experts to discuss and collaborate on the latest research & drugs available in combating and curing age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, uveitis and other eye diseases at the Ocular Diseases & Drug Discovery conference.
The keynote presentation will be given by Pete Adamson, Head of Research for Ophthiris at GlaxoSmithKline
For more information on attending, presenting a poster, or sponsoring, please visit http://gtcbio.com/conferenceDetails.aspx?id=143
About GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
---
Press release service and press release distribution provided by http://www.24-7pressrelease.com# # #
Read more Press Releases from Rania Hafez:- Joost Oppenheim, M.D., Laboratory Chief - NCI, to give Keynote Presentation at GTCbio's 8th Cytokines & Inflammation Conference on January 28-29, 2010 in San Diego, CA
- Vaccines: All Things Considered Conference to be held by GTCbio on November 9-10, 2009 in Washington, DC
- Translational Medicine Track of the GTCbio 5th Annual Modern Drug Discovery & Development Conference to be held on October 14-16, 2009 in San Diego, CA
- Amy Scott-Billman, VP at GlaxoSmithKline to do Keynote at Modern Drug Discovery & Development Summit
- Biological Therapeutics to be an Important Focus at the 5th Modern Drug Discovery & Development Summit held by GTCbio on October 14-16, 2009 in San Diego, CA.
- GTCbio Announces 4th Annual Assay Development and Screening Conference taking place June 8-9, 2009.
- Dr. Joseph Bolen, CSO of Millennium to give Keynote Presentation at GTCbio's 4th Annual Protein Kinases in Drug Discovery Conference taking place on May 4-5, 2009 in Boston, MA
- Pete Adamson, Head of Research for Ophthiris at GlaxoSmithKline to give Keynote Presentation at GTCbio's Inaugural Ocular Diseases & Drug Discovery conference, taking place on April 20-21, 2009 in Philadelphia, PA.
- Alison Goss Eng of US Dept. of Energy to Present at GTCbio's Inaugural Biofuels: Science and Innovation for Sustainable Development Conference on June 29-30, 2009 in San Francisco, CA
- GTCbio Announces its Inaugural Ocular Diseases & Drug Discovery conference, taking place on April 20-21, 2009 in Philadelphia, Pennsylvania.
